Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2004-1-26
pubmed:abstractText
In advanced stages of prostate cancer, the phosphatidylinositol-3' kinase (PI3K)/Akt signaling cascade, one of the major survival pathways in the cell, is frequently constitutively activated due to mutation or loss of the tumor suppressor protein phosphatase and tensin homolog deleted on chromosome 10 (PTEN). Using cell culture models representing different tumor stages, we explored the effect of inhibition of this survival pathway on the induction of apoptosis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/2-(4-morpholinyl)-8-phenyl-4H-1-benz..., http://linkedlifedata.com/resource/pubmed/chemical/AKT1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Chromones, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Epidermal Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I, http://linkedlifedata.com/resource/pubmed/chemical/Morpholines, http://linkedlifedata.com/resource/pubmed/chemical/Neuregulin-1, http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0270-4137
pubmed:author
pubmed:copyrightInfo
Copyright 2003 Wiley-Liss, Inc.
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
58
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
259-68
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:14743465-Androgen Antagonists, pubmed-meshheading:14743465-Apoptosis, pubmed-meshheading:14743465-Cell Line, Tumor, pubmed-meshheading:14743465-Chromones, pubmed-meshheading:14743465-Drug Resistance, pubmed-meshheading:14743465-Enzyme Inhibitors, pubmed-meshheading:14743465-Epidermal Growth Factor, pubmed-meshheading:14743465-Humans, pubmed-meshheading:14743465-Insulin-Like Growth Factor I, pubmed-meshheading:14743465-Male, pubmed-meshheading:14743465-Morpholines, pubmed-meshheading:14743465-Neuregulin-1, pubmed-meshheading:14743465-Phosphatidylinositol 3-Kinases, pubmed-meshheading:14743465-Prostatic Neoplasms, pubmed-meshheading:14743465-Protein-Serine-Threonine Kinases, pubmed-meshheading:14743465-Proto-Oncogene Proteins, pubmed-meshheading:14743465-Proto-Oncogene Proteins c-akt, pubmed-meshheading:14743465-Time Factors
pubmed:year
2004
pubmed:articleTitle
Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
pubmed:affiliation
Department of Urology, University of Innsbruck, Austria.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't